Key facts
- This page summarizes Lori M. Henderson's Form 4 filing for Moderna, Inc. (MRNA).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 May 2021, 08:45.
Lori M. Henderson - 27 May 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)
- Reporting relationship
- General Counsel and Secretary
- Issuer ticker
- MRNA
- Reported as of
- 27 May 2021
- Net transaction value
- -$1,051,710
- SEC form
- 4
- Accepted by SEC
- 28 May 2021, 08:45:21 UTC
- Prior SEC filing
- 27 May 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Sandstrom, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Lori M. Henderson filed Form 4 for Moderna, Inc. (MRNA) on 28 May 2021.
Change
- Previous filing in this sequence was filed on 27 May 2021.
- Current net transaction value: -$1,051,710.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MRNA
transaction
Common Stock
Options Exercise
- Transaction value
- $98,010
- Shares
- +6,600
- Change %
- +733%
- Price
- $14.85*
- Shares after
- 7,501
- Date
- 27 May 2021
- Ownership
- Direct
- Footnotes
- F1
MRNA
transaction
Common Stock
Sale
- Transaction value
- $1,149,720
- Shares
- -6,600
- Change %
- -88%
- Price
- $174.20
- Shares after
- 901
- Date
- 27 May 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MRNA
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -6,600
- Change %
- -2%
- Price
- $0.000000
- Shares after
- 328,352
- Date
- 27 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,600
- Exercise price
- $14.85
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
Footnote F2
25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.